Bridgebio Pharma Inc

BBIO's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

BBIO Growth rates comparisons

Looking into Bridgebio Pharma Inc growth rates, revenue grew by 4318.01 % in the third quarter of 2025 from the same quarter a year ago. Ranking at No. 14

Major Pharmaceutical Preparations industry recorded growth of revenues by 10.1 %

Bridgebio Pharma Inc net loss increased from $-164 millions, to $-185 millions in third quarter of 2025,

• More on BBIO's Growth

BBIO's Valuation comparisons

Bridgebio Pharma Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 58.8 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 39.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.18.

• More on BBIO's Valuation

Total Debt (Millions $)	564
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	1,360,692
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	4.52
Tangible Book Value (Per Share $)	-10.17

BBIO's Valuation comparisons

Bridgebio Pharma Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 58.8 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 39.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.18.

• More on BBIO's Valuation

• Market Capitalization (Millions $)	13,948
• Shares Outstanding (Millions)	192
• Employees	260
• Revenues (TTM) (Millions $)	354
• Net Income (TTM) (Millions $)	-806
• Cash Flow (TTM) (Millions $)	237
• Capital Exp. (TTM) (Millions $)	-13
• Total Debt (Millions $)	564
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	1,360,692
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	4.52
• Tangible Book Value (Per Share $)	-10.17

• Market Capitalization (Millions $)	13,948
• Shares Outstanding (Millions)	192
• Employees	260
• Revenues (TTM) (Millions $)	354
• Net Income (TTM) (Millions $)	-806
• Cash Flow (TTM) (Millions $)	237
• Capital Exp. (TTM) (Millions $)	-13

	*Ratio*
• Capital Ratio (MRQ)	3.88
• Total Debt to Equity (MRQ)	-
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.37
• Inventory Turnover Ratio (TTM)	1.28

BBIO's Profitability Comparisons

• More on BBIO's Key Ratios

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.